Motor performance as assessed by the MDS-UPDRS part 3 test battery in the off state (no l-DOPA given) did not change at all in the drug group after 12 months of treatment, while the control group deteriorated rapidly over time
40 Less common side effects included dyspepsia, fatigue, headache, eructation (belching), hair loss, gastroesophageal reflux, dizziness, and gastritis (Table 2)
Emerging discussions around next-generation treatments such as retatrutide further suggest that online communities are already looking beyond today's leading offerings and actively shaping expectations for what comes next
Drug Therapies for Diabetes
Ozempic and Mounjaro are approved for type 2 diabetes
Purification by preparative HPLC afforded the disulfide linker functionalized (+)-MK-801 (70%) and inactive MK-801 (70%)